ASIT Biotech

    OverviewSuggest Edit

    ASIT Biotech is a clinical-stage biopharmaceutical company, which focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies. The Comany's products include gp-ASIT+ for the treatment of grass pollen allergy administered by subcutaneous injections; hdm-ASIT+ for the treatment of house dust mite allergy administered by subcutaneous injections; and food-ASIT+ for the treatment of peanut, cow's milk, and egg white allergies.

    TypePublic
    Founded1997
    HQSint-Lambrechts-Woluwe, BE
    Websiteasitbiotech.com

    Latest Updates

    Employees (est.) (Feb 2019)26(+30%)

    Key People/Management at ASIT Biotech

    Thierry Legon

    Thierry Legon

    CEO
    Everard van der Straten

    Everard van der Straten

    CFO
    Vincent Bille

    Vincent Bille

    Vice-President CMC
    Sabine Pirotton

    Sabine Pirotton

    Head of Research and Development
    Gilles Della Corte

    Gilles Della Corte

    Chief Medical Officer
    Vincent Theunissen

    Vincent Theunissen

    Head of Human Resources
    Show more

    ASIT Biotech Office Locations

    ASIT Biotech has an office in Sint-Lambrechts-Woluwe
    Sint-Lambrechts-Woluwe, BE (HQ)
    5 Arianelaan
    Show all (1)

    ASIT Biotech Online and Social Media Presence

    Embed Graph

    ASIT Biotech News and Updates

    ASIT Biotech Continues its Transformation From Research to Late Stage Clinical Development

    BRUSSELS, Belgium, July 01, 2019 (GLOBE NEWSWIRE) -- ASIT biotech (ASIT - BE0974289218), a clinical stage biopharmaceutical company focused on the research, development and future commercialization of breakthrough immunotherapy products for the treatment of allergies, announces that shareholders h…

    ASIT Biotech Blogs

    ASIT biotech mode of action study of gp-ASIT+™ for grass pollen allergy published in The Journal of Allergy and Clinical Immunology (JACI)

    ASIT biotech mode of action study of gp-ASIT+™ for grass pollen allergy published in The Journal of Allergy and Clinical Immunology (JACI)

    ASIT biotech receives GMP certification for its manufacturing site in Liège, Belgium

    ASIT biotech receives GMP certification for its manufacturing site in Liège, Belgium

    ASIT biotech firmly on course for readout of Phase III clinical study in grass pollen allergy

    ASIT biotech firmly on course for readout of Phase III clinical study in grass pollen allergy

    ASIT biotech presents its 2019 half year results and provides further update on its clinical programs until end-2019

    ASIT biotech presents its 2019 half year results and provides further update on its clinical programs until end-2019

    ASIT biotech conference calendar H2 2019

    ASIT biotech conference calendar H2 2019

    Successful pollen season confirms ASIT biotech on track for Phase III results of gp-ASIT+TM in December 2019

    Successful pollen season confirms ASIT biotech on track for Phase III results of gp-ASIT+TM in December 2019
    Show more

    ASIT Biotech Frequently Asked Questions

    • When was ASIT Biotech founded?

      ASIT Biotech was founded in 1997.

    • Who are ASIT Biotech key executives?

      ASIT Biotech's key executives are Thierry Legon, Everard van der Straten and Vincent Bille.

    • How many employees does ASIT Biotech have?

      ASIT Biotech has 26 employees.

    • Who are ASIT Biotech competitors?

      Competitors of ASIT Biotech include Gilead Sciences, BioSpecifics Technologies and Neurogastrx.

    • Where is ASIT Biotech headquarters?

      ASIT Biotech headquarters is located at 5 Arianelaan, Sint-Lambrechts-Woluwe.

    • Where are ASIT Biotech offices?

      ASIT Biotech has an office in Sint-Lambrechts-Woluwe.

    • How many offices does ASIT Biotech have?

      ASIT Biotech has 1 office.